Dr Zagnoni presented a talk on CAR-T efficacy using our Screenin3D platform at the Festival of Biologics

Screenin3D microfluidic technology is a game-changing approach for pre-clinical drug and therapy testing. At the Festival of Biologics in Basel, Dr Zagnoni presented a talk on our bespoke Onco-Chip^3D technology used for the screening of combination immunotherapies with CAR-Ts and their off-target cytotoxicity.